Citation: | Zhou Wei, Li Bailing, Zhang Guanxin, et al. Effect of preoperative pulmonary artery pressure on perioperative prognosis of recipients with end-stage heart failure undergoing heart transplantation[J]. ORGAN TRANSPLANTATION, 2023, 14(1): 100-105. doi: 10.3969/j.issn.1674-7445.2023.01.013 |
[1] |
SHAH KS, KITTLESON MM, KOBASHIGAWA JA. Updates on heart transplantation[J]. Curr Heart Fail Rep, 2019, 16(5): 150-156. DOI: 10.1007/s11897-019-00432-3.
|
[2] |
郑珊珊, 郑哲, 宋云虎, 等. 心脏移植术后移植物血管病: 阜外医院单中心长期随访结果总结[J]. 器官移植, 2022, 13(2): 206-212. DOI: 10.3969/j.issn.1674-7445.2022.02.008.
ZHENG SS, ZHENG Z, SONG YH, et al. Cardiac allograft vasculopathy after heart transplantation: summary of a single-center long-term follow-up experience in Fuwai Hospital[J]. Organ Transplant, 2022, 13(2): 206-212. DOI: 10.3969/j.issn.1674-7445.2022.02.008.
|
[3] |
POLASKA P, JERZAK-WODZYNSKA G, SMIGIELSKI W, et al. Long term outcome of heart failure patients disqualified from heart transplantation[J]. Acta Cardiol, 2021, 76(5): 525-533. DOI: 10.1080/00015385.2020.1852755.
|
[4] |
ABU T, LEVI A, HASDAI D, et al. Preoperative evaluation of pulmonary hypertension in lung transplant candidates: echocardiography versus right heart catheterization[J]. BMC Cardiovasc Disord, 2022, 22(1): 53. DOI: 10.1186/s12872-022-02495-y.
|
[5] |
SIMONNEAU G, MONTANI D, CELERMAJER DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension[J]. Eur Respir J, 2019, 53(1): 1801913. DOI: 10.1183/13993003.01913-2018.
|
[6] |
王辉山. 终末期心力衰竭外科治疗新进展[J]. 创伤与急危重病医学, 2022, 10(3): 161-163. DOI: 10.16048/j.issn.2095-5561.2022.03.01.
WANG HS. Recent advances in surgical treatment of end-stage heart failure[J]. Trauma Crit Care Med, 2022, 10(3): 161-163. DOI: 10.16048/j.issn.2095-5561.2022.03.01.
|
[7] |
BOLLANO E, ANDERSSON B, HJALMARSSON C, et al. Early post-transplant elevated pulmonary artery pressure predicts adverse outcome in cardiac recipients[J]. Int J Cardiol Heart Vasc, 2019, 26: 100438. DOI: 10.1016/j.ijcha.2019.100438.
|
[8] |
VACHIÉRY JL, TEDFORD RJ, ROSENKRANZ S, et al. Pulmonary hypertension due to left heart disease[J]. Eur Respir J, 2019, 53(1): 1801897. DOI: 10.1183/13993003.01897-2018.
|
[9] |
AL-OMARY MS, SUGITO S, BOYLE AJ, et al. Pulmonary hypertension due to left heart disease: diagnosis, pathophysiology, and therapy[J]. Hypertension, 2020, 75(6): 1397-1408. DOI: 10.1161/HYPERTENSIONAHA.119.14330.
|
[10] |
郑珊珊, 刘盛. 终末期心力衰竭合并可逆性肺动脉高压患者心脏移植指征的探讨[J]. 器官移植, 2021, 12(2): 239-243. DOI: 10.3969/j.issn.1674-7445.2021.02.017.
ZHENG SS, LIU S. Discussion on heart transplantation indications in patients with end-stage heart failure complicated with reversible pulmonary artery hypertension[J]. Organ Transplant, 2021, 12(2): 239-243. DOI: 10.3969/j.issn.1674-7445.2021.02.017.
|
[11] |
CHAMBERS DC, PERCH M, ZUCKERMANN A, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-eighth adult lung transplantation report - 2021; focus on recipient characteristics[J]. J Heart Lung Transplant, 2021, 40(10): 1060-1072. DOI: 10.1016/j.healun.2021.07.021.
|
[12] |
中华医学会器官移植学分会. 中国心脏移植受者术前评估与准备技术规范(2019版)[J/CD]. 中华移植杂志(电子版), 2019, 13(1): 1-7. DOI: 10.3877/cma.j.issn.1674-3903.2019.01.001.
Branch of Organ Transplantation of Chinese Medical Association. Technical specification for preoperative evaluation and preparation of heart transplant recipients in China (2019 edition)[J/CD]. Chin J Transplant (Electr Edit), 2019, 13(1): 1-7. DOI: 10.3877/cma.j.issn.1674-3903.2019.01.001.
|
[13] |
郑珊珊, 刘盛, 宋云虎, 等. 终末期心力衰竭合并肺动脉高压患者心脏移植的预后[J]. 中国循环杂志, 2022, 37(3): 226-233. DOI: 10.3969/j.issn.1000-3614.2022.03.004.
ZHENG SS, LIU S, SONG YH, et al. Prognosis of end-stage heart failure patients with pulmonary hypertension post heart transplantation[J]. Chin Circ J, 2022, 37(3): 226-233. DOI: 10.3969/j.issn.1000-3614.2022.03.004.
|
[14] |
CRAWFORD TC, LEARY PJ, FRASER CD 3RD, et al. Impact of the new pulmonary hypertension definition on heart transplant outcomes: expanding the hemodynamic risk profile[J]. Chest, 2020, 157(1): 151-161. DOI: 10.1016/j.chest.2019.07.028.
|
[15] |
YAKUT K, VARAN B, ERDOĞAN İ, et al. Management of pediatric cardiac transplantation candidates with pulmonary hypertension and high pulmonary vascular resistance[J]. Turk J Pediatr, 2020, 62(3): 461-467. DOI: 10.24953/turkjped.2020.03.013.
|
[16] |
GALIÈ N, HUMBERT M, VACHIERY JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)[J]. Eur Heart J, 2016, 37(1): 67-119. DOI: 10.1093/eurheartj/ehv317.
|
[17] |
MATKOVIC M, MILICEVIC V, BILBIJA I, et al. Pulmonary artery hypertension as a risk factor for long-term survival after heart transplantation[J]. Heart Surg Forum, 2021, 24(3): E544-E549. DOI: 10.1532/hsf.3789.
|
[18] |
BIEŁKA A, KALINOWSKI M, HAWRANEK M, et al. Mechanical circulatory support restores eligibility for heart transplant in patients with significant pulmonary hypertension[J]. Kardiol Pol, 2020, 78(10): 1008-1014. DOI: 10.33963/KP.15518.
|
[19] |
MANDRAS SA, MEHTA HS, VAIDYA A. Pulmonary hypertension: a brief guide for clinicians[J]. Mayo Clin Proc, 2020, 95(9): 1978-1988. DOI: 10.1016/j.mayocp.2020.04.039.
|
[20] |
HUSTON JH, BRITTAIN EL, ROBBINS IM. Pulmonary hypertension and right ventricular failure: lung transplant versus heart-lung transplant[J]. Cardiol Clin, 2020, 38(2): 269-281. DOI: 10.1016/j.ccl.2020.01.002.
|
[21] |
COSTARD-JÄCKLE A, HILL I, SCHROEDER JS, et al. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation[J]. Circulation, 1991, 84(5 Suppl): Ⅲ329-Ⅲ 337.
|
[22] |
MOAYEDIFAR R, ZUCKERMANN A, ALIABADI-ZUCKERMANN A, et al. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices[J]. Eur J Cardiothorac Surg, 2018, 54(6): 1116-1121. DOI: 10.1093/ejcts/ezy214.
|
[23] |
AL-KINDI SG, FARHOUD M, ZACHARIAS M, et al. Left ventricular assist devices or inotropes for decreasing pulmonary vascular resistance in patients with pulmonary hypertension listed for heart transplantation[J]. J Card Fail, 2017, 23(3): 209-215. DOI: 10.1016/j.cardfail.2016.06.421.
|
[24] |
李雨琪, 贾明, 韩杰, 等. 心脏移植受者术后中远期疗效及死亡危险因素分析[J]. 中国医药, 2022, 17(1): 37-41. DOI: 10.3760/j.issn.1673-4777.2022.01.009.
LI YQ, JIA M, HAN J, et al. Analysis of mid-to long-term efficacy and risk factors for death in patients after heart transplantation[J]. Chin Med, 2022, 17(1): 37-41. DOI: 10.3760/j.issn.1673-4777.2022.01.009.
|
[25] |
胡盛寿, 董念国, 魏翔, 等. 我国心脏移植现状分析——2013年中国心脏移植年度报告[J]. 中华器官移植杂志, 2014, 35(6): 324-328. DOI: 10.3760/cma.j.issn.0254-1785.2014.06.002.
HU SS, DONG NG, WEI X, et al. Current situation of heart transplantation: Chinese heart transplant annual report 2013[J]. Chin J Organ Transplant, 2014, 35(6): 324-328. DOI: 10.3760/cma.j.issn.0254-1785.2014.06.002.
|
[26] |
LUND LH, EDWARDS LB, KUCHERYAVAYA AY, et al. The registry of the international society for heart and lung transplantation: thirty-second official adult heart transplantation report--2015; focus theme: early graft failure[J]. J Heart Lung Transplant, 2015, 34(10): 1244-1254. DOI: 10.1016/j.healun.2015.08.003.
|
[27] |
VAKIL K, DUVAL S, SHARMA A, et al. Impact of pre-transplant pulmonary hypertension on survival after heart transplantation: a UNOS registry analysis[J]. Int J Cardiol, 2014, 176(3): 595-599. DOI: 10.1016/j.ijcard.2014.08.072.
|
[28] |
TAYLOR DO, EDWARDS LB, BOUCEK MM, et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report--2004[J]. J Heart Lung Transplant, 2004, 23(7): 796-803. DOI: 10.1016/j.healun.2004.05.004.
|
[29] |
BIRATI EY, RAME JE. Post-heart transplant complications[J]. Crit Care Clin, 2014, 30(3): 629-637. DOI: 10.1016/j.ccc.2014.03.005.
|
[30] |
黄洁. 阜外医院200例心脏移植病人中期生存率和影响因素与ISHLT结果对比分析研究[D]. 北京: 北京协和医学院(中国医学科学院), 2010.
|